{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:14:00Z","timestamp":1793103240094,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jacc.2022.11.050","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T14:41:37Z","timestamp":1676299297000},"page":"684-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Bleeding Events After Transcatheter Aortic Valve Replacement"],"prefix":"10.1016","volume":"81","author":[{"given":"Marisa","family":"Avvedimento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8269-2244","authenticated-orcid":false,"given":"Jorge","family":"Nuche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio I.","family":"Farjat-Pasos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Rod\u00e9s-Cabau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2022.11.050_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.11.050_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.jacc.2022.11.050_bib3","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.jacc.2022.11.050_bib4","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.jacc.2022.11.050_bib5","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.jacc.2022.11.050_bib6","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.jacc.2022.11.050_bib7","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.jacc.2022.11.050_bib8","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.jacc.2015.03.014","article-title":"Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial","volume":"65","author":"Thyregod","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.jacc.2022.11.050_bib9","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.jacc.2022.11.050_bib10","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.jacc.2022.11.050_bib11","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2013.03.029","article-title":"Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events","volume":"62","author":"Rod\u00e9s-Cabau","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.jacc.2022.11.050_bib12","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2019.08.1032","article-title":"Thrombotic versus bleeding risk after transcatheter aortic valve replacement: JACC review topic of the week","volume":"74","author":"Mangieri","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.jacc.2022.11.050_bib13","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2012.02.022","article-title":"Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies","volume":"59","author":"G\u00e9n\u00e9reux","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.jacc.2022.11.050_bib14","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.jacc.2014.08.052","article-title":"Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement","volume":"64","author":"G\u00e9n\u00e9reux","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jacc.2022.11.050_bib15","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jcin.2017.04.034","article-title":"Frequency, timing, and impact of access-site and non-access-site bleeding on mortality among patients undergoing transcatheter aortic valve replacement","volume":"10","author":"Piccolo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"21","key":"10.1016\/j.jacc.2022.11.050_bib16","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jacc.2022.11.050_bib17","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.jacc.2022.11.050_bib18","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"33","author":"Kappetein","year":"2012","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2022.11.050_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2018.09.041","article-title":"Blood disorders in patients undergoing transcatheter aortic valve replacement: a review","volume":"12","author":"De Larochelli\u00e8re","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijcard.2016.09.009","article-title":"Blood oozing: a cause of life-threatening bleeding without overt source after transcatheter aortic valve replacement","volume":"224","author":"Tarantini","year":"2016","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.jacc.2022.11.050_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009026","article-title":"Early adverse impact of transfusion after transcatheter aortic valve replacement: a propensity-matched comparison from the TRITAVI registry","volume":"13","author":"Zimarino","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.jacc.2022.11.050_bib22","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2018.08.2143","article-title":"Primary hemostatic disorders and late major bleeding after transcatheter aortic valve replacement","volume":"72","author":"Kibler","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.11.050_bib23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamacardio.2017.0265","article-title":"Mortality, length of stay and cost implications of procedural bleeding after percutaneous interventions using large-bore catheters","volume":"2","author":"Redfors","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2022.11.050_bib24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jcin.2018.11.008","article-title":"Impact of short-term complications on mortality and quality of life after transcatheter aortic valve replacement","volume":"12","author":"Arnold","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ehjqcco\/qcaa001","article-title":"Impact of short-term complications of transcatheter aortic valve replacement on longer-term outcomes: results from the STS\/ACC Transcatheter Valve Therapy Registry","volume":"7","author":"Arnold","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"9","key":"10.1016\/j.jacc.2022.11.050_bib26","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jcin.2020.01.238","article-title":"Frailty and bleeding in older adults undergoing TAVR or SAVR: insights from the FRAILTY-AVR study","volume":"13","author":"Bendayan","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"22","key":"10.1016\/j.jacc.2022.11.050_bib27","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.jacc.2019.09.015","article-title":"Sex differences in transfemoral transcatheter aortic valve replacement","volume":"74","author":"Vlastra","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.11.050_bib28","article-title":"Sex-specific considerations in degenerative aortic stenosis for female-tailored transfemoral aortic valve implantation management","volume":"11","author":"Masiero","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"33","key":"10.1016\/j.jacc.2022.11.050_bib29","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/eurheartj\/ehu279","article-title":"Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A \u201cstate-of-the-art\u201d paper","volume":"35","author":"Patti","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.11.050_bib30","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jcin.2017.07.044","article-title":"Association of chronic kidney disease with in-hospital outcomes of transcatheter aortic valve replacement","volume":"20","author":"Gupta","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib31","first-page":"E172","article-title":"Impact of bleeding after transcatheter aortic valve replacement in patients with chronic kidney disease","volume":"97","author":"Li","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.jacc.2022.11.050_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005456","article-title":"Peripheral artery disease and transcatheter aortic valve replacement outcomes: a report from the Society of Thoracic Surgeons\/American College of Cardiology Transcatheter Therapy Registry","volume":"10","author":"Fanaroff","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.11.050_bib33","first-page":"1009","article-title":"Impact of new-onset versus pre-existing atrial fibrillation on outcomes after transcatheter aortic valve replacement\/implantation","volume":"38","author":"Nso","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jacc.2022.11.050_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002766","article-title":"Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valve (PARTNER) trial","volume":"9","author":"Biviano","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.11.050_bib35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCINTERVENTIONS.113.000409","article-title":"Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation","volume":"6","author":"Nuis","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.11.050_bib36","first-page":"1231","article-title":"Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry)","volume":"85","author":"Arai","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.jacc.2022.11.050_bib37","first-page":"E44","article-title":"Baseline anemia and its impact on midterm outcome after transcatheter aortic valve implantation","volume":"89","author":"Seiffert","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.11.050_bib38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjcard.2014.11.033","article-title":"Effect on outcomes and exercise performance of anemia in patients with aortic stenosis who underwent transcatheter aortic valve replacement","volume":"115","author":"DeLarochelli\u00e8re","year":"2015","journal-title":"Am J Cardiol"},{"issue":"20","key":"10.1016\/j.jacc.2022.11.050_bib39","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJMcibr1205363","article-title":"From clinical observation to mechanism\u2014Heyde\u2019s syndrome","volume":"367","author":"Loscalzo","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.jacc.2022.11.050_bib40","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcin.2015.02.008","article-title":"Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement","volume":"8","author":"Spangenberg","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1505643","article-title":"Von Willebrand factor multimers during transcatheter aortic-valve replacement","volume":"375","author":"Van Belle","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.11.050_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.011848","article-title":"Reduction of gastrointestinal bleeding in patients with Heyde syndrome undergoing transcatheter aortic valve implantation","volume":"15","author":"Goltstein","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.11.050_bib43","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1093\/eurheartj\/ehu082","article-title":"Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes","volume":"35","author":"Dvir","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.11.050_bib44","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010225","article-title":"Transfusion and mortality after transcatheter aortic valve replacement: association or causation?","volume":"13","author":"Costa","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.11.050_bib45","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/eurheartj\/ehy435","article-title":"Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis","volume":"40","author":"Shehata","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.11.050_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008227","article-title":"Incidence, temporal trends, and associated outcomes of vascular and bleeding complications in patients undergoing transfemoral transcatheter aortic valve replacement: insights from STS\/ACC TVT registry","volume":"13","author":"Sherwood","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.11.050_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.006388","article-title":"Transcarotid compared with other alternative access routes for transcatheter aortic valve replacement","volume":"11","author":"Chamandi","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.11.050_bib48","article-title":"Femoral versus nonfemoral subclavian\/carotid arterial access route for transcatheter aortic valve replacement: a systematic review and meta-analysis","volume":"9","author":"Faroux","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2022.11.050_bib49","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jcin.2022.03.014","article-title":"Transcaval versus transaxillary TAVR in contemporary practice: a propensity-weighted analysis","volume":"15","author":"Lederman","year":"2022","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcin.2020.09.052","article-title":"Suture- or plug-based large-bore arteriotomy closure: a pilot randomized controlled trial","volume":"14","author":"van Wiechen","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib51","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCULATIONAHA.121.057856","article-title":"Comparison of a pure plug-based versus a primary suture-based vascular closure device strategy for transfemoral transcatheter aortic valve replacement: the CHOICE-CLOSURE randomized clinical trial","volume":"145","author":"Abdel-Wahab","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.11.050_bib52","article-title":"Comparison of transfemoral versus transradial secondary access in transcatheter aortic valve replacement","volume":"13","author":"Junquera","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.11.050_bib53","first-page":"918","article-title":"Use of two-dimensional ultrasonographically guided access to reduce access-related complications for transcatheter aortic valve replacement","volume":"33","author":"Elbaz-Greener","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2022.11.050_bib54","first-page":"432","article-title":"Ultrasound guided vascular access site management and left ventricular pacing are associated with improved outcomes in contemporary transcatheter aortic valve replacement: insights from the OxTAVI registry","volume":"96","author":"Kotronias","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.11.050_bib55","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jcin.2020.03.047","article-title":"Routine ultrasound or fluoroscopy use and risk of vascular\/bleeding complications after transfemoral TAVR","volume":"13","author":"Witberg","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib56","first-page":"1387","article-title":"Impact of HAS-BLED score to predict trans femoral transcatheter aortic valve replacement outcomes","volume":"92","author":"Honda","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.jacc.2022.11.050_bib57","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4244\/EIJ-D-21-01048","article-title":"Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2","volume":"18","author":"Garot","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2022.11.050_bib58","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jcin.2021.03.024","article-title":"Development and validation of a practical model to identify patients at risk of bleeding after TAVR","volume":"14","author":"Navarese","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"15","key":"10.1016\/j.jacc.2022.11.050_bib59","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jcin.2021.06.020","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement","volume":"14","author":"Capodanno","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib60","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehab196","article-title":"Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions","volume":"42","author":"Ten Berg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.11.050_bib61","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jcin.2020.03.041","article-title":"Safety and efficacy of protamine administration for prevention of bleeding complications in patients undergoing TAVR","volume":"13","author":"Al-Kassou","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib62","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.jacc.2015.10.003","article-title":"Bivalirudin versus heparin anticoagulation in transcatheter aortic valve replacement: the randomized BRAVO-3 trial","volume":"66","author":"Dangas","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.11.050_bib63","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.amjcard.2019.01.049","article-title":"Usefulness of clopidogrel loading in patients who underwent transcatheter aortic valve implantation (from the BRAVO-3 randomized trial)","volume":"123","author":"Nijenhuis","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2022.11.050_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcin.2020.09.062","article-title":"Safety and efficacy of transcatheter aortic valve replacement with continuation of vitamin K antagonists or direct oral anticoagulants","volume":"14","author":"Brinkert","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib65","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jcin.2017.04.014","article-title":"Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE trial","volume":"10","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"3","key":"10.1016\/j.jacc.2022.11.050_bib66","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijcard.2014.04.170","article-title":"SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation","volume":"174","author":"Stabile","year":"2014","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.jacc.2022.11.050_bib67","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.amjcard.2011.07.049","article-title":"Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation","volume":"108","author":"Ussia","year":"2011","journal-title":"Am J Cardiol"},{"issue":"15","key":"10.1016\/j.jacc.2022.11.050_bib68","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.jacc.2022.11.050_bib69","article-title":"Aspirin alone versus dual antiplatelet therapy after transcatheter aortic valve implantation: a systematic review and patient-level meta-analysis","volume":"10","author":"Brouwer","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.jacc.2022.11.050_bib70","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41569-019-0314-y","article-title":"Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease","volume":"17","author":"Capodanno","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2022.11.050_bib71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1911426","article-title":"Reduced leaflet motion after transcatheter aortic valve replacement","volume":"382","author":"De Backer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"29","key":"10.1016\/j.jacc.2022.11.050_bib72","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/eurheartj\/ehac242","article-title":"Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial","volume":"43","author":"Collet","year":"2022","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacc.2022.11.050_bib73","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A\u00a0controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jacc.2022.11.050_bib74","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.122.059512","article-title":"Edoxaban versus dual antiplatelet therapy for leaflet thrombosis and cerebral thromboembolism after TAVR: the ADAPT-TAVR randomized clinical trial","volume":"146","author":"Park","year":"2022","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacc.2022.11.050_bib75","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010097","article-title":"Aspirin versus clopidogrel as single antithrombotic therapy after TAVR: insight from the OCEAN-TAVI registry","volume":"14","author":"Kobari","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.jacc.2022.11.050_bib76","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcin.2018.10.005","article-title":"Assessment of platelet REACtivity after transcatheter aortic valve replacement: the REAC-TAVI trial","volume":"12","author":"Jimenez Diaz","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib77","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.amjcard.2021.05.047","article-title":"Comparison of ticagrelor versus clopidogrel on cerebrovascular microembolic events and platelet inhibition during transcatheter aortic valve implantation","volume":"154","author":"Vavuranakis","year":"2021","journal-title":"Am J Cardiol"},{"issue":"18","key":"10.1016\/j.jacc.2022.11.050_bib78","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.jacc.2022.11.050_bib79","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jcin.2021.05.025","article-title":"TAVR patients requiring anticoagulation: direct oral anticoagulant or vitamin K antagonist?","volume":"14","author":"Didier","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"23","key":"10.1016\/j.jacc.2022.11.050_bib80","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.11.050_bib81","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.jcin.2020.04.044","article-title":"Vascular access site for TAVR: use the approach you master best","volume":"13","author":"Mesnier","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib82","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jcin.2011.05.019","article-title":"Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation","volume":"4","author":"Genereux","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib83","first-page":"E302","article-title":"Clinical impact of crossover techniques for primary access hemostasis in transfemoral transcatheter aortic valve replacement procedures","volume":"33","author":"Junquera","year":"2021","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jacc.2022.11.050_bib84","first-page":"283","article-title":"Transradial crossover balloon occlusion technique for primary access hemostasis during transcatheter aortic valve replacement: initial experience with the Oceanus 140\u00a0cm and 200\u00a0cm balloon catheters","volume":"32","author":"Junquera","year":"2020","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jacc.2022.11.050_bib85","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jcin.2016.04.038","article-title":"One-stop shop\u201d: safety of combining transcatheter aortic valve replacement and left atrial appendage occlusion","volume":"9","author":"Attinger-Toller","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"18","key":"10.1016\/j.jacc.2022.11.050_bib86","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jacc.2018.09.005","article-title":"Paravalvular leak: an interesting interplay of acquired vWF-disease and late bleeding after TAVR","volume":"72","author":"Mehran","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.11.050_bib87","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.jcin.2019.09.029","article-title":"Left ventricular rapid pacing via the valve delivery guidewire in transcatheter aortic valve replacement","volume":"12","author":"Faurie","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.11.050_bib88","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.4244\/EIJ-D-22-00190","article-title":"A\u00a0pressure wire for rapid pacing, valve implantation and continuous haemodynamic monitoring during transcatheter aortic valve implantation procedures","volume":"18","author":"Rod\u00e9s-Cabau","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2022.11.050_bib89","first-page":"255","article-title":"First-in-human study of the Saranas Early Bird Bleed Monitoring System for the detection of endovascular procedure-related bleeding E events","volume":"32","author":"G\u00e9n\u00e9reux","year":"2020","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jacc.2022.11.050_bib90","first-page":"249","article-title":"Safety and accuracy of a novel bioimpedance system for real-time detection and monitoring of endovascular procedure-related bleeding in a porcine model","volume":"32","author":"G\u00e9n\u00e9reux","year":"2020","journal-title":"J\u00a0Invasive Cardiol"},{"issue":"12","key":"10.1016\/j.jacc.2022.11.050_bib91","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.amjcard.2011.02.325","article-title":"Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin","volume":"107","author":"Bartolucci","year":"2011","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2022.11.050_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160046","article-title":"Bleeding risk with long-term low-dose aspirin: a systematic review of observational studies","volume":"11","author":"Garc\u00eda Rodr\u00edguez","year":"2016","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.jacc.2022.11.050_bib93","first-page":"E737","article-title":"Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: predictors and bail-outs","volume":"98","author":"van Wiechen","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.jacc.2022.11.050_bib94","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.jvs.2020.03.035","article-title":"Incidence, predictors, impact, and treatment of vascular complications after transcatheter aortic valve implantation in a modern prospective cohort under real conditions","volume":"72","author":"Langouet","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"issue":"10","key":"10.1016\/j.jacc.2022.11.050_bib95","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.amjcard.2018.01.050","article-title":"Incidence, predictors, and impact of vascular complications after transfemoral transcatheter aortic valve implantation with the SAPIEN 3 prosthesis","volume":"121","author":"van Kesteren","year":"2018","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2022.11.050_bib96","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.carrev.2020.01.007","article-title":"Incidence, prognosis and predictors of major vascular complications and percutaneous closure device failure following contemporary percutaneous transfemoral transcatheter aortic valve replacement","volume":"21","author":"Batchelor","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"issue":"11","key":"10.1016\/j.jacc.2022.11.050_bib97","first-page":"1437","article-title":"2019 Canadian Cardiovascular Society position statement for transcatheter aortic valve implantation","volume":"35","author":"Asgar","year":"2019","journal-title":"Can J Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722076227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722076227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:55:51Z","timestamp":1760018151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109722076227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":97,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0735109722076227"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2022.11.050","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding Events After Transcatheter Aortic Valve Replacement","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2022.11.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}